Grassley, Baucus Press for Details of UnitedHealth CEO’s Exit Compensation Package Amid Stock Options Backdating Scandal
WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, and Sen. Max Baucus, ranking member, today asked the UnitedHealth Group a series of questions to gauge the appropriateness of a reported $1.1 billion exit compensation package for the company’s chief executive officer amid allegations of a stock options backdating scandal. “You can’t pick […]
Chairman Grassley works to help states save Medicaid dollars
Grassley works to help states save Medicaid dollars when other insurers should pay for services WASHINGTON — Sen. Chuck Grassley is continuing his effort to help state governments identify and require payment of responsible third parties for health care services that are provided through Medicaid. “It’s not fair for taxpayers to get stuck with bills […]
Letter from the GAO Office of Congressional Affairs to Sen. Grassley
SEE RELATED FILE
Grassley Seeks Multi-Agency Response on Lack of Hedge Fund Transparency, Expresses Alarm at Risk to Pension-holders
WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, today asked all federal agencies of jurisdiction to report to him on any transparency requirements facing hedge funds, and whether their agencies could require more transparency. Grassley expressed alarm that millions of pension-holders are in the dark about their exposure to hedge fund losses […]
Grassley Praises Overall Reduction in Improper Payments by Medicare
WASHINGTON — Sen. Chuck Grassley today praised efforts by the Centers for Medicare & Medicaid Services to reduce improper Medicare payments. “I welcome the news that the government’s increased attention to oversight of Medicare payments has paid off,” Grassley said. “I’ve always supported efforts to ensure that Medicare dollars are used appropriately. Every dollar that’s […]
Sen. Grassley Comments on FDA Letter on Compounding of Inhalation Drugs
M E M O R A N D U M TO: Reporters and Editors FR: Jill Kozeny, 202/224-1308 for Sen. Grassley RE: Compounding of Inhalation Drugs DA: October 13, 2006 Earlier this month, Sen. Chuck Grassley received a response from the Food and Drug Administration to a letter he sent in July asking for the […]
Chairman Grassley Works to Safeguard Medicare Payments
WASHINGTON— Sen. Chuck Grassley today said that the federal government needs to keep up-to-date the focus of the program that’s responsible for safeguarding the integrity of Medicare payments. “The Medicare Integrity Program plays an important role in making sure that Medicare payments aren’t made improperly and therefore wasted,” Grassley said. “Medicare officials need to make […]
Grassley asks FDA for more information about unapproved prescription drugs
WASHINGTON – Sen. Chuck Grassley has asked the Food and Drug Administration for more information about its review of prescription drugs that are currently on the market without an FDA approval. “There are many physicians and pharmacists under the impression that drugs they administer to patients are safe, and approved by the U.S. government,” Grassley […]
Sen. Grassley Asks HHS Secretary to Review Ethics of FDA-Approved Research
WASHINGTON — Sen. Chuck Grassley, Chairman of the Senate Committee on Finance, today urged the Secretary of Health and Human Services to review the ethics and science of human research that was approved by the Food and Drug Administration and conducted without the voluntary consent of its subjects. Grassley made his request as the Food […]
Sen. Grassley comments on Customs Decision to Stop Crackdown on Imported Irescription Drugs
M E M O R A N D U M TO: Reporters and Editors FR: Jill Kozeny, 202/224-1308 for Chairman Grassley RE: Imported Prescription Drugs DA: Thursday, Oct. 5, 2006 Sen. Chuck Grassley, Chairman of the Senate Committee on Finance, issued the comment below regarding the decision of United States Customs and Border Protection to […]